GlassScriptPhysician profile
Karen M Wrigley
NPI 1558374074
$6,492.43
in general payments reported to CMS, 2019-2025
20 companies · $637 in 2025
The $637 reported for 2025 was more than what 83% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $947 · 2020: $289 · 2021: $789 · 2022: $1,419 · 2023: $1,590 · 2024: $822 · 2025: $637.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,049 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,048.81 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $2,521.06 | 2019-2025 | Precision 1, Dailies Total1, Dailies Total1 Multifocal |
| Coopervision INC. | $900.87 | 2019-2025 | Myday Contact Lens, Clariti Contact Lens, Paragon Crt |
| Johnson & Johnson Vision Care, INC. | $695.28 | 2019-2025 | Acuvue |
| Bausch & Lomb Americas INC. | $522.36 | 2022-2025 | Infuse, Revive, Miebo |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $506.80 | 2019-2021 | |
| Allergan, INC. | $224.00 | 2019-2022 | |
| Astellas Pharma US INC | $142.04 | 2025 | Izervay |
| Visionix USA, INC | $140.00 | 2022 | |
| Biotissue Holdings INC. | $139.45 | 2019-2025 | |
| Sun Pharmaceutical Industries INC. | $138.05 | 2020-2022 | |
| Dompe US, INC. | $113.49 | 2025 | Oxervate |
| Optovue, INC. | $108.99 | 2019 | |
| Amgen INC. | $89.74 | 2024 | Tepezza |
| Genzyme Corporation | $79.99 | 2022 | |
| Abbvie INC. | $46.35 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec Ag | $38.80 | 2020 | |
| Mallinckrodt Hospital Products INC. | $29.79 | 2021 | |
| Oyster Point Pharma, INC. | $21.85 | 2023 | Tyrvaya |
| Carl Zeiss Meditec, INC. | $17.24 | 2020 | |
| Menicon America INC | $16.28 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karen Wrigley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.